Related Experiment Video
Updated: Jul 14, 2026
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.9K
D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study
Bartosz Szmyd1, Patrycja Stanisławska1, Małgorzata Podstawka1
1Department of Neurosurgery and Neuro-Oncology, Barlicki University Hospital, Medical University of Lodz, 90-153 Lodz, Poland.
International Journal of Molecular Sciences
|April 27, 2024
Summary
Mitochondrial DNA D-loop mutations may predict glioblastoma outcomes. The m.16126T>C variant was linked to shorter survival in glioblastoma patients, suggesting its potential as a prognostic biomarker.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Glioblastoma is an aggressive brain tumor with limited treatment options.
- Understanding molecular complexity is key for new biomarkers and therapies.
- Mitochondrial DNA (mtDNA) D-loop mutations are understudied in glioblastoma.
Purpose of the Study:
- To investigate the prognostic significance of the mitochondrial DNA D-loop m.16126T>C variant in glioblastoma.
- To explore potential diagnostic and therapeutic implications of mtDNA variants.
Main Methods:
- Prospective case-control study design.
- Immunohistochemistry and droplet digital PCR (ddPCR) for mutation analysis.
- Statistical analyses including log-rank test and literature review.
Main Results:
- The mtDNA D-loop m.16126T>C variant was found in 18% of glioblastoma samples.
- Patients with the m.16126T>C variant exhibited significantly shorter median survival (9.5 vs. 18 months).
Conclusions:
- The mtDNA D-loop m.16126T>C variant shows potential as a prognostic biomarker for glioblastoma.
- Further research into mtDNA variants may reveal novel therapeutic targets for glioblastoma.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...